Unlocking Medical Marvels: Dassault Systemes Living Heart Project

▴ Dassault Systemes
As the 'virtual twin' continues to evolve, its impact on medical research, treatment methodologies, and cost efficiencies holds tremendous promise for the future of global healthcare.

In a groundbreaking initiative, Dassault Systemes has harnessed the power of technology to create a 'virtual twin' of the human heart, revolutionizing the way doctors understand and treat patients. This project, known as the Living Heart project, has not only opened new frontiers in medical science but has also showcased the potential of Artificial Intelligence (AI) and machine learning in saving lives.

The Journey to a Virtual Heart: Dassault Systemes, a French company with a rich history in creating virtual models of complex machines, embarked on an extraordinary journey—a ten-year endeavour to build a 'virtual twin' of the human heart. Unlike machines such as automobiles or aircraft, replicating the intricacies of the human heart posed a unique challenge. Dr. Steve Levine, Senior Director of Virtual Human Modeling at Dassault Systemes, highlighted the complexity of the task, emphasizing the lack of a virtual counterpart in the medical field for testing treatments.

A Global Collaboration for Heart Health: The Living Heart project brought together experts, researchers, and doctors from over 150 organizations across 49 countries. This collaborative effort resulted in a 3D 'virtual twin' of the human heart, a physics-based model that mimics the real heart's operations. This model, powered by AI, allows doctors to simulate heart diseases and run intricate simulations, providing valuable insights into potential complications.

Transformative Impact on Healthcare: The 'virtual twin' heart has become a catalyst for transformative changes in healthcare. Beyond simulations, this technological marvel is being utilized by companies like Sahajanand Medicals in India to create personalized stents at a fraction of the cost. Drug companies and medical device manufacturers leverage the virtual heart to gauge the impact of medicines and instruments on the organ.

Real-Life Success Stories: Dr. Levine shared a compelling example of the Boston Children's Hospital utilizing the 3D 'virtual twin' to tackle complex cases successfully (source: The Indian Express). In one instance, a toddler's life was saved by accurately predicting the optimal surgical procedure using the virtual model. Such success stories underscore the potential of this technology to revolutionize medical procedures and decision-making.

Customization for Optimal Results: The 'virtual twin' heart isn't a one-size-fits-all model. AI algorithms enable customization for each patient, ensuring optimal results. This cloud-based platform facilitates global collaboration, allowing doctors worldwide to benefit from shared data and procedures.

Beyond the Heart: The Future of Virtual Twins-Dassault Systemes envisions extending the concept of 'virtual twins' beyond the heart. The company is actively exploring creating virtual counterparts for the human brain and liver. While challenges exist, especially in understanding complex organs like the brain, the potential benefits for pharmaceutical companies in understanding drug impact on the liver are immense.

Challenges and Future Prospects: Dr Levine acknowledges the challenges in modelling organs like the brain, where mysteries still prevail. Despite these hurdles, the company aims to create a 'virtual liver' within a year. While the full functionality may take a decade, the promise of advancements in medical science remains unwavering.

Bridging the Business Challenge: Developing such advanced systems comes with a significant cost. Dassault faces the 'business challenge' of convincing hospitals and insurance companies that this technology can lead to long-term cost reduction in healthcare. Dr. Levine emphasizes the need to prove the cost-saving benefits and points to the positive outcomes observed in Boston.

Dassault Systemes Living Heart project stands as a ray of innovation, showcasing the extraordinary possibilities when technology and healthcare converge. As the 'virtual twin' continues to evolve, its impact on medical research, treatment methodologies, and cost efficiencies holds tremendous promise for the future of global healthcare

Tags : #dassault #livingheart #technology #AI #artificialintelligence #machinelearning #humanheart #virtual #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cancer in a Glass? What Science Says About Your Favourite WineMarch 27, 2025
BluHeat by Nysh.in Launches Innovative Cough Decongestion PatchesMarch 27, 2025
Jindal IVF plans to expand its presence in Himachal Pradesh and UPMarch 27, 2025
PartySmart Becomes India’s Go-To ‘Anti-Hangover Partner’ Across the Biggest Cultural FestivalsMarch 27, 2025
March 27, 2025
American Institute of Pathology & Laboratory Sciences (Ampath) in Collaboration Expands its Diagnostic Services in PunjabMarch 26, 2025
AI Prodigy at 14: The Boy Who Might Save Millions from Heart DiseaseMarch 26, 2025
Delhi Finally Joins Ayushman Bharat But Is It Too Late to Fix Its Healthcare Crisis?March 26, 2025
Why Epilepsy Awareness Day Should Matter to EveryoneMarch 26, 2025
Why Epilepsy Awareness Day Should Matter to EveryoneMarch 26, 2025
A $10 Million Bet on Life: How Everhope Oncology Plans to Fix India’s Cancer CareMarch 26, 2025
Honoring Changemakers: Lighthouse Canton Supports Rotary Club of Bombay’s Shakti Awards 2025 as Platinum SponsorMarch 26, 2025
Death in the Shadows: What’s Behind the Rising Child Fatalities in Jharkhand?March 26, 2025
The Future of Autism Therapy? Why Roper is Betting Big on CentralReachMarch 25, 2025
Scientists unveil world-leading technology to speed up drug discoveryMarch 25, 2025
Moscow Scientists Develop Questionnaire to Evaluate Doctors' Trust in AI Services: A Tool for International StudiesMarch 25, 2025
Indian MedTech Leader Remidio invests in UK’s Occuity to Enhance Non-Invasive Global Disease ScreeningMarch 25, 2025
HRV Global Life Sciences Strengthens Global Presence at DCAT Week 2025 in New YorkMarch 25, 2025
Ola Electric-Ola Electric Settles Rosmerta Dues, Insolvency Petitions WithdrawnMarch 25, 2025
6 Symptoms of Kidney Disease You Shouldn’t IgnoreMarch 25, 2025